Securities Report - 70th Fiscal Period (2025/04/01 - 2026/03/31)
Key facts
- Securities Report - 70th Fiscal Period (2025/04/01 - 2026/03/31)
- Toho Pharmaceutical Co., Ltd. has filed its Securities Report for the 70th fiscal period (April 1, 2025 to March 31, 2026), disclosing financial performance, business strategy, and future outlook.
- Source: EDINET
- Date: Mon Jun 22 2026 21:00:00 GMT+0900 (Japan Standard Time)
Direct answer
Toho Pharmaceutical Co., Ltd. has filed its Securities Report for the 70th fiscal period (April 1, 2025 to March 31, 2026), disclosing financial performance, business strategy, and future outlook.
- Citation
- Securities Report - 70th Fiscal Period (2025/04/01 - 2026/03/31) (Mon Jun 22 2026 21:00:00 GMT+0900 (Japan Standard Time)), EDINET
- Source
- EDINET
- Date
- Mon Jun 22 2026 21:00:00 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
Toho Pharmaceutical Co., Ltd. has filed its Securities Report for the 70th fiscal period (April 1, 2025 to March 31, 2026), disclosing financial performance, business strategy, and future outlook.
AI Analysis
Frequently Asked Questions
- Q: What is a Securities Report?
- A: A mandatory annual disclosure by listed companies, containing financial and strategic information for investors.
- Q: What are Toho Pharmaceutical's key therapeutic areas?
- A: The company focuses on central nervous system and chronic disease treatments.
- Q: What is the dividend forecast for this fiscal year?
- A: The report outlines planned interim and year-end dividends.